Internal Medicine, Pulmonary Disease · Rock Hill, SC
NPI
1366435422
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
370 S Herlong Ave Ste 100
Rock Hill, SC, 29732
Phone (803) 329-6903
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
40,079 services
Medicare patients, 2024
289
Average age 73
Drug cost, 2024
$3.6M
4,806 prescriptions
Company payments, 2025
$1,007
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arun Adlakha was code 95165 (treatment - miscellaneous), 5,970 times for 38 patients. In total Arun Adlakha billed 40,079 services in 55 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 5,970 | 38 | $10.37 | $62K |
| 95004 Test - Miscellaneous | Office | 4,480 | 64 | $2.42 | $11K |
| 94010 Pulmonary Function Testing | Office | 328 | 182 | $18.22 | $5,975 |
| 99214 Office E&M - Established | Office | 230 | 119 | $89.23 | $21K |
| 99213 Office E&M - Established | Office | 161 | 104 | $57.80 | $9,305 |
| 96366 Intravenous Infusion, Hydration | Office | 97 | 12 | $14.50 | $1,407 |
| 96365 Intravenous Infusion, Hydration | Office | 93 | 33 | $43.43 | $4,039 |
| 96372 Injection Administration | Office | 76 | 29 | $10.30 | $783 |
| 99204 Office E&M - New | Office | 58 | 58 | $109.05 | $6,325 |
| 96413 Chemotherapy Administration | Office | 33 | 14 | $85.94 | $2,836 |
| 95115 Treatment - Miscellaneous | Office | 29 | 26 | $7.34 | $213 |
By year: 2022 $1.8M for 38,477 services; 2023 $1.0M for 38,532 services; 2024 $1.0M for 40,079 services.
Medicare prescription drug claims, 2024
In 2024, the drug Arun Adlakha prescribed most often to Medicare patients was Montelukast Sodium, with 612 prescriptions and refills. In total Arun Adlakha wrote 4,806 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 612 | 1,639 | 207 | $7,334 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 524 | 616 | 141 | $14K |
| Theophylline Er Theophylline Anhydrous | 446 | 997 | 136 | $75K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 414 | 823 | 123 | $519K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 411 | 741 | 131 | $462K |
| Prednisone Generic | 350 | 551 | 155 | $1,254 |
| Levofloxacin Generic | 172 | 172 | 106 | $914 |
| Roflumilast Generic | 153 | 344 | 40 | $16K |
| Alprazolam Generic | 118 | 190 | 25 | $666 |
| Symbicort Budesonide/Formoterol Fumarate | 113 | 186 | 26 | $44K |
| Breo Ellipta Fluticasone/Vilanterol | 97 | 157 | 25 | $60K |
| Ofev Nintedanib Esylate | 94 | 94 | 14 | $1.2M |
| Incruse Ellipta Umeclidinium Bromide | 63 | 117 | 15 | $40K |
| Furosemide Generic | 56 | 86 | Under 11 | $107 |
| Epinephrine Generic | 52 | 68 | 41 | $10K |
Brand drugs: - claims; generic drugs: 2,931 claims; opioid claims: 76.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arun Adlakha $1,007 ($1,007 in general payments such as food, travel and fees) from 11 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $251.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $251 |
| Genzyme Corporation SNY | 6 | $197 |
| Verona Pharma, Inc. VRNA | 3 | $156 |
| GlaxoSmithKline, LLC. GSK | 4 | $89.04 |
| United Therapeutics Corporation UTHR | 3 | $74.91 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $57.48 |
| Grifols USA, LLC | 3 | $52.28 |
| Pfizer Inc. PFE | 2 | $39.4 |
| Insmed, Inc. INSM | 2 | $38.36 |
| CSL Behring CSL.AX | 2 | $31.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.